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A B S T R A C T
Objective: To investigate factors that might influence the recurrence of both painful symptoms and
endometriotic lesions following laparoscopic treatment of endometriosis.
Study design: Retrospective cohort study in a University teaching hospital. We reviewed data from
patients referred for laparoscopy between March 1993 and November 2007. We selected women who
were followed up throughout Transvaginal-ultrasound (TV-US) after a first conservative laparoscopy for
endometriosis. After laparoscopy, all patients were followed up according to an internal protocol: a
standard gynaecologic examination, the assessment of painful symptoms and a TV-US scan that were
repeated at 3, 6, and 12 months, and subsequently on a yearly basis. Sixteen factors were assessed by
univariable and multivariable Cox proportional hazards models to evaluate their associations with
recurrence of endometriotic lesions and pain related-endometriosis.
Results: 401 women were enrolled. A total of 154 (38.4%) experienced moderate or severe pain after
laparoscopy; endometriotic lesions were observed by TV-US in 74 (18.4%) patients. In the multivariable
model, age at menarche, severity of chronic pelvic pain (CPP) and dysmenorrhoea prior to surgery were
significant risk factors for recurrence/occurrence of pain. Age at the first laparoscopy, stage of disease,
pre-operative severity of CPP, and pregnancy were predictive factors of the recurrence for such lesions.
Conclusion: The severity of CPP prior to the first laparoscopy showed the only significant factor in the
overall prediction of recurrence of pain and endometriotic lesions. Patients with severe CPP at the time of
their first surgerymight represent a sub-group of womenwith amore aggressive form of endometriosis.
 2011 Elsevier Ireland Ltd. All rights reserved.
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The existence of a relationship between pain and endometriosis
iswidely accepted by gynaecologists [1,2]. Laparoscopic excision of
endometriosis results in pain relief, improved reproductive out-
comes, and increased quality of life. Unfortunately, even with
surgeons experienced in laparoscopy, 6–51% of women will have a
recurrence of endometriosis within 5 years of surgery [3,4].
Few studies have analysed the determinants of recurrence rate
in endometriosis, and the available data are controversial. The
inconsistencies found in literaturemay be due to the complexity of
endometriosis itself or to widespread methodological problems in
the current studies: (i) limited and/or heterogeneous samples, (ii)
few studies conducted with a second-look surgery, (iii) failure to
control for endometriosis stage and symptomatology, as well as
(iv) use of improper statistical analyses. Although some authors* Corresponding author at: via Ippolito Nievo, 2- Firenze, Italy. Tel.: +39 335
6346293; fax: +39 055 88431171.
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doi:10.1016/j.ejogrb.2011.02.008have considered recurrence of pain (dysmenorrhoea, dyspareunia
or chronic pelvic pain) [3,5] ultrasound findings [3,5–7] or
increased CA125 levels [3,5] to be the definition of endometriosis
recurrence, there is still absence of a standardised definition.
The aim of this study was to analyse the effectiveness of
laparoscopic treatment of endometriosis and to assess prognostic
factors that might influence the recurrence rate for pain and
endometriosis.
In a further analysis, we hypothesised that patients with
recurrence/occurrence of pelvic pain may be at increased risk for
the recurrence of endometriosis and sought to investigate this
relationship.
2. Materials and methods
We reviewed the medical records of 593 consecutive patients
who underwent laparoscopy for endometriosis between March
1993 and November 2007 in the Department of Gynaecology,
Perinatology and Human Reproduction at the University of
Florence, Italy. Inclusion criteria were: first conservative laparos-
copy for endometriosis, diagnosis of endometriosis histologically-up after laparoscopic treatment for endometriosis: multivariate
esions and pain. Eur J Obstet Gynecol (2011), doi:10.1016/
Table 1
Characteristics of 401 selected patients.
Mean SD/Num. (%)
Age (years) (mean SD) at the time of surgery 32.36.1
Menarche (years) (mean SD) 12.41.4
BMI (kg/m2 SD) 22.23.7
Mean follow-up duration (years) (mean SD) 6.24.1
Pain before surgery 278 (69.3%)
Dysmenorrhea 271
Dyspareunia 144
Chronic pelvic pain 181
Infertility before surgery 216 (53.8%)
Duration of infertility (years) (mean SD)
before surgery
3.62.6
Stages I–II (Num) 114 (28.4%)
Stages III–IV (Num) 287 (71.6%)
Pregnancies after surgery 174 (43.4%)
Post-operative medication 261 (65.1%)
GnRHa only 199 (76.2%) (3–9 months)
GnRHa and add-back 25 (9.6%) (3–24 months)
Oral contraceptives 31 (11.9%) (3–36 months)
Danatrol 6 (2.3%) (2–6 months)
Women submitted to ART after surgery 90 (22.4%)
SD, standard deviation; GnRHa, Gonadotropin-releasing hormone analogues; ART,
assisted reproductive technology.
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roscopy. Following these criteria, 401 womenwere included in our
study.
All surgeries were performed by three expert laparoscopists. In
all cases, the surgical procedures aimed to remove all visible
implants of endometriosis. During surgery, disease staging was
assigned according to the American Society for Reproductive
Medicine (ASRM) classification system [8]. The presence, localiza-
tion, and extent of typical powder-burn and subtle lesions,
adhesions, and deep infiltrating implants were recorded. After
adhesiolysis, endometriomas were removed by stripping, excision
of deep endometriosis was performed, and peritoneal implants
were coagulated with bipolar forceps. Specimens underwent
thorough histological analysis. When complications occurred,
laparoscopy was converted into laparotomy. Laparotomic conver-
sions were not included in the study.
In our centre, all patients are followed up according to an
internal protocol. A standard gynaecologic examination and a TV-
US scan are performed before surgery and at 3, 6, and 12 months,
and then yearly after surgery. Menstrual-reproductive factors and
painful symptoms are also evaluated.
During follow-up visits, patients were asked whether dysmen-
orrhoea, pelvic pain or dyspareunia occurred during the follow-up
period. The time of their first appearance and the intensity of pain
symptoms after laparoscopy were also documented.
Chronic pelvic pain (CPP) was defined as noncyclic pelvic pain
of at least 3 months’ duration or cyclic pain of 6 months’ duration,
which interferes with one’s normal daily living activities [2].
Pain was rated on the basis of a 10-cm visual analogue scale
(VAS), and the intensity was divided into none (0), mild (1–4),
moderate (5–7), or severe (8–10). Presence of pain before surgery
and pain recurrence/occurrence were defined on the basis of a VAS
pain score of >5. Threshold points defining different severity of
pain were chosen based on previous correlation analysis [7].
Persistent pain was defined as pain still present 2 or 3 months
after surgery. Pain recurrence was defined on the basis of a
postoperative VAS pain score of >5 in women with preoperative
pain symptoms after a period of at least 3 months of relief. Pain
occurrence was defined as symptoms presenting after surgery in
patients who were asymptomatic at the time of laparoscopy.
Ultrasound recurrence was defined as the presence of an
endometriotic cyst or nodule observed during a TV-US. In
particular, an ovarian endometrioma was identified by the
presence of a cystic ovarian mass characterised by persistent
circular, homogeneous, hypoechoic ‘‘tissue’’ without papillary
proliferations that had a clear demarcation from the ovarian
parenchyma [9–12] and a diameter of more than 2 cm. Ovarian
nodules were defined lesions smaller than 20 mm in mean
diameter. Deep endometriosis implants, particularly those with
rectosigmoid and rectovaginal septum involvement, were sus-
pected from the presence of hypoechoic linear thickening or
nodules/masses, with or without regular contours, that had thin
band-like echoes departing from the centre of the mass that were
described as ‘Indian head dress’ type [13].
Approval for the study was obtained by the local Institution
review board.
2.1. Statistical analysis
The normality of the distribution of data was tested by
Kolmogorov–Smirnov test. Student’s t-test was used to compare
continuous variables and Fisher’s exact test or the chi-square test
to compare categorical variables.
The Kaplan–Meier method was used to calculate the cumula-
tive probability of women presenting with recurrence/occurrence
of pain and recurrent endometriosis at TV-US. Patients entered thePlease cite this article in press as: Coccia ME, et al. Long-term follow
analysis of predictive factors for recurrence of endometriotic l
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after the end of post-operative medication, if any. When GNRH
analogues were prescribed, they entered the study 1 month after
the last injection. The events under study were recurrence of
endometriosis diagnosed by TV-US and recurrence/occurrence of
pain. Caseswere considered censored if, at the end of the study, the
event under observation had not occurred or the patientwas lost to
follow-up. The statistical significance for the survival curves
obtained was assessed by the Mantel–Cox log rank test.
The following characteristics were analysed: age at the time of
surgery, age at menarche, body mass index (BMI), presence of
painful symptoms before surgery, infertility as indication for
surgery, duration of infertility, primary/secondary infertility,
ASRM stages, tubal patency, post-operative medication, attempts
at assisted reproductive technology (ART), number of in vitro
fertilisation (IVF)/intra cytoplasmic sperm injection (ICSI) cycles,
number of intrauterine insemination (IUI) cycles, and occurrence
of pregnancy after surgery.
We identified potential risk factors (p < 0.1) for recurrence/
occurrence of pelvic pain and TV-US recurrence of endometriosis
using univariable Cox proportional hazards models and entered
them into the multivariable Cox proportional hazards models.
We defined significance as p < 0.05 and conducted the
statistical analysis using SPSS 13.0 (SPSS, Inc., Chicago, IL).
3. Results
Among 593 consecutive patients submitted to laparoscopy for
endometriosis, 401 (67.6%) underwent periodic TV-US after
surgery (114 with stage I or II endometriosis; 287 with stage III
or IV endometriosis). Themean duration of observation per patient
was 6.2  4.1 years (median time 6 years, range 2–11 years). Table 1
shows the general features of the sample that received TV-US after
surgery (Table 1).
3.1. Pain recurrence
Of the 401 patients, a total of 154 (38.4%) women experienced
at least one period of moderate or severe pain after laparoscopy. Of
278 women suffering from painful symptoms before surgery, 140
(50.3%) did not experience such symptoms after laparoscopic
treatment, 138 (49.6%) lamented pain after surgery.-up after laparoscopic treatment for endometriosis: multivariate
esions and pain. Eur J Obstet Gynecol (2011), doi:10.1016/
Fig. 1. Box-plots with distribution of pain recurrence, occurrence and persistence
after surgery and the time to the onset of pain or censoring. Each bar denotes the
median value as a horizontal line, and the box itself represents the area containing
the top and the bottom quartile. Outliers (greater than 1.5 times the interquartile
range) are represented outside the boxes. The bars indicate the time to the onset of
pain or censor.
Fig. 2. Cumulative recurrence rate of pelvic pain. (A) All patients; (B) stratified
according to stages (Log Rank (Mantel–Cox chi square 1832; p = 0.176).
Fig. 3. Box-plots showing distribution of TV-US recurrence and persistence after
surgery.
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were excluded from the analysis. Patients with persistent pain
were mainly diagnosed with a more severe disease (30, 69.8%,
patients with persistent pain were diagnosed III–IV stages). The
study of the pattern of pain-recurrences after laparoscopy revealed
5 cases of recurrence occurring 145 months after surgery (Fig. 1);
these cases were also excluded in order to remove clinical and
statistical outliers. Thus, analysis was conducted on the remaining
106 patients with pain after surgery.
In 90 (84.9%), pain recurred after a period of at least 3months of
pain relief after surgery (pain recurrence). Twenty-one (23.3%) of
them with minimal-mild endometriosis, 69 (76.7%) moderate-
severe stage. For 16 patients (15.1%), pelvic pain was experienced,
for the first time, after surgery (pain occurrence), 6 in patients with
stages I–II, 10 in stages III–IV. The median time to the onset of pain
recurrence was 24 months and 12 months for pain occurrence.
The graph shows the results of Kaplan–Meier analysis of time to
pain recurrence. Cumulative recurrence rate at the end of the study
was 42.5% for stages I–II and 46.5% for stages III–IV (Log Rank,
Mantel–Cox chi square 1832; p = 0.176). Cumulative recurrence
rate after 60months were 22.7% for stages I–II, 29.8% for stages III–
IV, after 120 months 34.6% for stages I–II, 42.5% for stages III–IV
(Fig. 2a and b).
Menarche, severity of CPP and dysmenorrhoea before surgery
remained significant risk factors for recurrence/occurrence of pain
in themultivariable Cox proportional hazardsmodel (Hazard ratio:
0.645, 95% CI: 0.496–0.838, p: 0.001; Hazard ratio: 1.128, 95% CI:
1.024–1.242, p: 0.014; Hazard ratio: 1. 236, 95% CI: 1.035–1.476, p:
0.019, respectively) (Tables 2 and 3).
The risk of pain recurrence was significantly higher for women
who had early menarche (11.9  1.5 years versus 12.7  1.3 years)
as well as for those who reported more severe CPP and dysmenor-
rhoea before laparoscopic treatment.
3.2. TV-US endometriosis recurrence
Of the 401 patients who received the TV-US follow-up,
endometriotic lesions were observed in 74 women (18.4%). In 9
cases, endometriotic lesions were observed in the first follow-up
visit, which occurred within the 3rd month. Thus, they were
considered persistent lesions and excluded from the analysis.Please cite this article in press as: Coccia ME, et al. Long-term follow-up after laparoscopic treatment for endometriosis: multivariate
analysis of predictive factors for recurrence of endometriotic lesions and pain. Eur J Obstet Gynecol (2011), doi:10.1016/
j.ejogrb.2011.02.008
Table 2
Univariable Cox proportional Hazard models of potential risk factors for recurrence/occurrence of pain after laparoscopy for endometriosis.
Recurrence/occurrence
of pain 106
No recurrence/occurrence
of pain 247
Hazard ratio 95% CI p-Value
Age at surgery (years) 31.35 32.86.4 0.966 0.934–0.999 0.041
Menarche (years) 11.91.5 12.71.3 0.657 0.528–0.818 0.001
BMI (kg/m2) 22.73.8 21.93.9 0.883 0.895–1.100 0.883
Painful symptoms before surgery (Num. of patients) 90 (84.9%) 146 (59.1%) 4.013 2.353–6.845 0.001
CPP (VAS) 6.42.5 4.32.4 1.167 1.107–1.230 0.001
Dysmenorrhoea (VAS) 8.31.7 6.51.9 1.158 1.095–1.224 0.001
Dyspareunia (VAS) 5.12.3 3.72.3 1.120 1.052–1.193 0.001
Infertility as indication for surgery (Num.) 59 (55.7%) 137 (55.5%) 0.596 0.392–0.908 0.016
Duration of infertility (years SD) 3.62.8 3.82.6 1.003 0.874–1.153 0.961
Primary infertility (Num.) 36 (33.9%) 97 (39.3%) 0.816 0.320–2.082 0.671
Stages, I–II, III–IV 27 (25.5%), 79 (74.5%) 71 (28.7%), 176 (71.2%) 1.353 0.868–2.107 0.182
Post-operative medication 68 (64.1%) 172 (69.6%) 1.305 0.819–2.079 0.129
Monolateral or Bilateral Tubal patency
(in 311 patients performing laparoscopic dye)
89/92 (96.7%) 212/219 (96.8%) 1.055 0.334–3.335 0.928
ART attempts after surgery (yes/no) 26 (24.5%) 62 (25.1%) 1.141 0.694–1.878 0.603
IVF-ICSI cycles after surgery (Num.) 1.8 0.8 2.21.1 0.897 0.734–1.095 0.285
IUI cycles after surgery (Num.) 2.71.1 31.5 1.031 0.852–1.248 0.454
Pregnancy after surgery (Num. of patients) 41 (38.7%) 101 (40.9%) 0.776 0.523–1.150 0.206
CI, confidence interval; BMI, bodymass index; CPP, chronic pelvic pain; VAS, Visual Analogue Scale; SD, standard deviation; ART, assisted reproductive technology; IVF-ICSI, in
vitro fertilisation/intra cytoplasmic sperm injection; IUI, intrauterine insemination.
All values are expressed as mean SD for continuous variables, for categorial variables the number (percentage) of subjects are given.
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months after surgery in order to remove statistical outliers (Fig. 3).
Among the remaining patients, 64 recurrences were observed
in a median time of 24 months. More than half of all recurrences
(37, 56.9%) were observed within 3 years after the first
laparoscopy. According to the Kaplan–Meier analysis, the cumula-
tive recurrence rate was 12.5% for stages I–II, and 33.7% for stages
III–IV. Cumulative recurrence rates after 60 months were 6.3% for
stages I–II, and 19% for stages III–IV; after 120months 12.5% for I–II
stages, 32.7% III–IV stages. Women with minimal-mild disease at
surgery showed a significantly lower recurrence rate when
compared with those with more severe stages (Log Rank,
Mantel–Cox chi square 11,976; p = 0.001). (Fig. 4a and b).
In the multivariable analysis, age at first laparoscopy, stage of
disease, pre-operative severity of CPP, and pregnancy after surgery
showed statistically significant as independent predictors of
recurrence (Hazard ratio: 0.935, 95% CI: 0.895–0.977, p: 0.003;
Hazard ratio: 3.105, 95% CI: 1.452–6.640, p: 0.003; Hazard ratio:
1.101, 95% CI: 1.101–1.200, p: 0.028; Hazard ratio: 0.529, 95% CI:
0.304–0.921, p: 0.024, respectively; Tables 4 and 5).
The 64 patients who experienced a recurrence of endometriosis
underwent the first surgery for endometriosis at a mean age
significantly lower than those who did not (mean age 30.6  5.3
years versus 32.6  6.3 years, p = 0.019, respectively), had a more
severe stage of the disease (55, 19.8% recurrences among 278 stages
III–IV versus 9, 7.9%, among 114 stages I–II; p = 0.004), and had more
severe CPP, as scored by VAS before the first laparoscopy.Table 3
Multivariable Cox proportional Hazard models of risk factors associated with
recurrence of pain after laparoscopy.
Hazard ratio 95% CI P Value
Age at surgery (years) 1.023 0.971–1.078 0.388
Menarche (years) 0.645 0.496–0.838 0.001
Painful symptoms before surgery
(Num. of patients)
0.821 0.171–3.945 0.806
CPP (VAS) 1.128 1.024–1.242 0.014
Dysmenorrhoea (VAS) 1.236 1.035–1.476 0.019
Dyspareunia (VAS) 0.980 0.872–1.101 0.738
Infertility as indication for
surgery (Num.)
1.069 0.554–2.063 0.843
CI, confidence interval; CPP, chronic pelvic pain; VAS, Visual Analogue Scale; SD,
standard deviation.
Fig. 4. Cumulative recurrence rate of endometriosis detected by ultrasound: (A) all
patients; (B) stratified according to stage of disease (Log Rank Mantel–Cox chi
square 11,976; p = 0.001).
Please cite this article in press as: Coccia ME, et al. Long-term follow-up after laparoscopic treatment for endometriosis: multivariate
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Table 4
Univariable Cox proportional Hazard models of potential risk factors for recurrence of endometriosis diagnosed by TV-US.
Recurrence endometriosis
diagnosed by TV-US
64
No recurrence endometriosis
diagnosed by TV-US
327
Hazard
ratio
95% CI p-Value
Age at surgery (years) 30.65.3 32.66.3 0.943 0.904–0.985 0.008
Menarche (years) 12.41.4 12.51.4 0.970 0.770–1.223 0.799
BMI (Kg/m2) 21.82.5 22.34.1 0.927 0.822–1.047 0.223
Painful symptoms before surgery (Num. of patients) 48 (75%) 224 (68.5%) 1.657 0.940–2.920 0.081
CPP (VAS) 6.62.4 5.92.5 1.125 1.052–1.203 0.001
Dysmenorrhoea (VAS) 8.21.5 7.81.9 1.042 0.977–1.111 0.214
Dyspareunia (VAS) 5.71.9 4.92.4 1.108 1.022–1.201 0.012
Infertility as indication for surgery (Num.) 31 (48.4%) 178 (54.4%) 0.957 0.560–1.638 0.874
Duration of infertility (years SD) 3.62.8 3.82.7 0.933 0.793–1.097 0.399
Primary Infertility (Num.) 28 (43.7%) 116 (35.5%) 0.408 0.097–1.714 0.221
Stages
I–II
III–IV
9 (14.1%)
55 (85.9%)
105 (32.1%)
222 (67.9%)
3.025 1.494–6.123 0.002
Monolateral or Bilateral Tubal patency
(in 311 patients performing laparoscopic dye)
52 (81.2%) 279 (85.3%) 0.652 0.159–2.685 0.554
Post-operative medication 48 (75%) 205 (62.7%) 1.213 0.714–2.058 0.131
ART attempts after surgery (yes/no) 17 (26.6%) 72(22%) 0.995 0.552–1.792 0.985
IVF-ICSI cycles after surgery (Num.) 1.7 0.9 2.11.1 1.017 0.820–1.261 0.878
IUI cycles after surgery (Num.) 2.5 0.8 3.11.5 1.073 0.862–1.335 0.530
Pregnancy after surgery (Num. of patients) 20 (31.2%) 149 (45.6%) 0.513 0.298–0.880 0.015
CI, confidence interval; BMI, bodymass index; CPP, chronic pelvic pain; VAS, Visual Analogue Scale; SD, standard deviation; ART, assisted reproductive technology; IVF-ICSI, in
vitro fertilisation/intra cytoplasmic sperm injection; IUI, intrauterine insemination.
All values are expressed as mean SD for continuous variables, for categorial variables the number (percentage) of subjects are given.
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reduced risk of recurrence. Twenty pregnancies were observed
among patients with TV-US recurrences (20/64, 31.2%), and 149 in
patients who did not experience a recurrence (149/327, 45.6%)
(p = 0.048).
3.3. Pelvic pain and TV-US findings
The results concerning the number of recurrences observed
during the TV-US follow-up were compared with subjective
symptomatology. Of the 74 women with endometriotic lesions
detected during ultrasonographic follow-up, the majority (n = 51,
68.9%) showed recurrence of pain (p = 0.001). Symptomatic
recurrences showed similar prevalence in women with recurrent
ovarian endometrioma and those with other recurrent lesions
(nodule, deep lesions) (respectively 29/43, 67.4% and 22/31, 70.9%;
p = 0.945). On the other hand, pelvic pain was observed in 154
cases after the first surgery; of those cases, only 51 (33.1%) had
endometriosis as detected by TV-US, and only 24 (15.6%) required
further laparoscopy.
Patients showing both a painful and a TV-US recurrence were
significantly younger when compared to the rest of patients
(29.9  5.4 years versus 32.6  6.1 years, p = 0.003), had earlierTable 5
Multivariable Cox proportional Hazard models of risk factors associated with
recurrence of endometriosis diagnosed by TV-US.
Hazard
ratio
95% CI P Value
Age at surgery (years) 0.935 0.895–0.977 0.003
Stages (I and II versus III and IV) 3.105 1.452–6.640 0.003
Painful symptoms before surgery
(Num. of patients)
0.820 0.388–1.734 0.603
CPP (VAS) 1.101 1.101–1.200 0.028
Dyspareunia (VAS) 1.008 0.914–1.113 0.867
Pregnancy after surgery
(Num. of patients)
0.529 0.304–0.921 0.024
CI, confidence interval; BMI, body mass index; CPP, chronic pelvic pain; VAS, Visual
Analogue Scale; SD, standard deviation; ART, assisted reproductive technology; IVF-
ICSI, in vitro fertilisation/intra cytoplasmic sperm injection; IUI, intrauterine
insemination.
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occurred earlier (mean time of pain recurrence 31.4  42 months
versus 54.8  46 months, p = 0.001; mean time of TV-US recurrence
33.6  31.8 months versus 64.9  43.7 months, p = 0.001).
4. Comments
Our study confirms the effectiveness of treating endometriosis
with laparoscopic excision in order to reduce patients’ pain, a
finding also reported by others [14–17]. Of 278 women suffering
from painful symptoms before surgery, 140 (50.3%) did not
experience such symptoms after laparoscopic treatment. Of the
216 infertile women in our sample, 117 (54.2%) were able to
achieve pregnancy after surgery.
A younger age at menarche and dysmenorrhoea severity
demonstrated risk factors for pain recurrence. This is not so for
the recurrence of disease at TV-US. These findings show that the
presence of dysmenorrhoea is not a reliable predictor for the
diagnosis of endometriosis. In most studies of women with
dysmenorrhoea, the prevalence of endometriosis ranged between
30% and 40% [18]. However, the pain felt by women during
menstruation may be no less severe than the pain experienced by
women with endometriosis. Even though pain is a very subjective
matter, it is possible to hypothesise the relationship between
precocity and severity of dysmenorrhoea before surgery with pain
recurrence. This might be ascribed to the phenomenon often
referred to as ‘‘pain memory’’ [19,20]. It has been widely
demonstrated that both acute and chronic pain, when severe
enough or associated with inflammation, are able to produce the
phenomena of spinal memory. In other words, longer periods of
pain duringmenstruationmight be related to a higher likelihood of
pain recurrence after surgery. This is probably due to several
psychological or neurologic components, whereas it is not
necessarily due to a recurrence of endometriotic lesions.
ASRM staging system showed a prognostic value in predicting
the risk of endometriosis recurrence during TV-US follow-up. It
may arguable that incomplete surgery occurs in advanced
endometriosis due to access difficulties.In agreement with other
authors [5,6], we also identified a younger age at surgery as a risk
factor for endometriosis’ recurrence. This may be related to an-up after laparoscopic treatment for endometriosis: multivariate
esions and pain. Eur J Obstet Gynecol (2011), doi:10.1016/
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higher estrogen levels.
The benefits of pregnancy on endometriosis’ progression and
recurrence were also confirmed. Some evidence suggested that
early pregnancy may be prophylactic against the development of
endometriosis and could actually cause the regression of
established lesions [5,7,21]. The mechanisms postulated include
production of anovulation and amenorrhea, decidual change and
eventual necrosis induced within the lesions. Moreover, vaginal
parturition enlarges the internal ostium of the uterine cervix and
might decrease recurrences by reducing tubal transportation of
endometrial debris [22].
In our study, severe CPP was the only significant risk factor for
the recurrence of both painful symptoms and endometriotic
lesions after laparoscopy. Endometriosis is one of the most
prevalent gynaecologic diagnoses among women with recurrent
and progressive CPP. A previous study showed that out of 58
patients who presented to a pelvic pain centre for treatment, 48
(83%) had biopsy-confirmed active endometriosis [23].
Patients with severe CPP at the time of their first surgery might
represent a sub-group of women with an aggressive form of
endometriosis, that manifest a more sudden growth of lesions.
The occurrence of pain after surgery in previously asymptom-
atic patients might further support this hypothesis. Moen [24]
conducted a study in 39 asymptomatic women with endometri-
osis, diagnosed in conjunction with tubal sterilization, and
observed that pelvic pain after surgery was reported by 6% of
them. In our study, the occurrence of pelvic pain was observed in a
higher number of women (16/123, 13%), probably due to the larger
sample size. A valid explanation for pain occurrence after
conservative surgery for endometriosis might be the progressive
growth and inflammation of microscopic lesions remaining after
surgery.
Recent studies suggest that, in women with endometriosis,
mechanisms underlying pain and sensitivity to estrogen involve
the growth into the ectopic endometrial tissue of a nerve supply,
which could have a varied andwidespread influence on the activity
of neurons throughout the central nervous system [25,26]. Higher
endogenous estrogens production in young women is not only
critical for developing endometriosis but also modulate CPP
through a neuropathic mechanism involving changes in the
peripheral nervous system that sensitize the central response.
The presence of pain inwomenwithout visualized lesions at TV-US
might suggests a neuropathic mechanism involving changes in the
peripheral nervous system that sensitize the central response.
Our study’s power was limited by its retrospective analysis, the
self-selected control sub-group of patients choosing to have TV-US
follow-up, and the lack of second-look surgery. The strength of our
current study is (i) the long-term follow-up, (ii) the measurement
of 16 potential risk factors, and (iii) a careful statistical analysis
with survival analysis methodology. In addition, we have
examined our findings throughout TV-US which is the most
objective, non-invasive, and reproducible index of recurrence, with
a reported diagnostic accuracy for endometriomas >90% [27].
Additional research is needed in order to understand why
endometriosis associates so variably with pain symptoms andwhy
these symptoms are ameliorated by a hypoestrogenic state. Our
findings show that there is a significantly higher recurrence rate of
endometriotic lesions detected by TV-US in women suffering of
painful symptoms after conservative laparoscopy for endometri-
osis. With the exception of CPP, significant predictors of both pain
and ultrasonographic recurrence were different.Please cite this article in press as: Coccia ME, et al. Long-term follow
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